NEOGENOMICS INC — Director's Dealing 2022

Mar 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-03-01

Reporting Person: Dieter Cynthia J (Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-01	Common Stock	A	9341	—	Acquired	18774	Direct
2022-03-02	Common Stock	F	137	—	Disposed	18637	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-01	Stock Option (Right to Buy)	$21.41	A	22805	Acquired	2029-03-01	Common Stock (22805.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$28.35	2027-06-22	Common Stock (3968.0)	3968	Direct
Stock Option (Right to Buy)	$53.17	2028-03-02	Common Stock (7034.0)	7034	Direct

Footnotes

F1: On March 1, 2022, Ms. Dieter was granted 9,341 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.

F2: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock.

F3: On June 22, 2020, Ms. Dieter was granted 3,968 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F4: On March 2, 2021, Ms. Dieter was granted 7,034 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F5: On March 1, 2022, Ms. Dieter was granted 22,805 stock options. These options vest ratably over the first four anniversary dates of the grant date.